Delaware
|
001-36894
|
20-5338862
|
||
(State or other jurisdiction
of incorporation)
|
(Commission
File Number)
|
(I.R.S. Employer
Identification No.)
|
1 HaMada Street, Herziliya Pituach, Israel
|
4673335
|
|
(Address of Principal executive offices)
|
(Zip Code)
|
o
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
o
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
o
|
o
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Exhibit No.
|
Description
|
|
Exhibit 99.1
|
Press release dated May 9, 2016
|
SOLAREDGE TECHNOLOGIES, INC.
|
|||
Date: May 9, 2016
|
By:
|
/s/ Ronen Faier | |
Name: Ronen Faier | |||
Title: Chief Financial Officer |
Exhibit No.
|
Description
|
|
Exhibit 99.1
|
Press release dated May 9, 2016
|
|
·
|
Record revenue of $125.2 million, up 0.3% from last quarter and 44.9% year-over-year
|
|
·
|
GAAP gross margin of 32.5%
|
|
·
|
GAAP net income of $20.8 million
|
|
·
|
Non-GAAP net income of $23.3 million
|
|
·
|
416 Megawatts (AC) of inverters shipped
|
|
·
|
Revenues to be within the range of $125 million to $134 million;
|
|
·
|
Gross margins to be within the range of 29.0 % to 31.0%.
|
Three months ended
March 31,
|
Nine months ended
March 31,
|
|||||||||||||||
2016
|
2015
|
2016
|
2015
|
|||||||||||||
Unaudited
|
Unaudited
|
|||||||||||||||
Revenues
|
$ | 125,205 | $ | 86,399 | $ | 365,091 | $ | 226,658 | ||||||||
Cost of revenues
|
84,471 | 62,698 | 252,248 | 173,146 | ||||||||||||
Gross profit
|
40,734 | 23,701 | 112,843 | 53,512 | ||||||||||||
Operating expenses:
|
||||||||||||||||
Research and development, net
|
8,709 | 5,490 | 23,999 | 15,317 | ||||||||||||
Sales and marketing
|
8,826 | 6,422 | 25,903 | 17,541 | ||||||||||||
General and administrative
|
3,460 | 1,990 | 9,066 | 4,270 | ||||||||||||
Total operating expenses
|
20,995 | 13,902 | 58,968 | 37,128 | ||||||||||||
Operating income
|
19,739 | 9,799 | 53,875 | 16,384 | ||||||||||||
Financial income (expenses), net
|
2,029 | (3,436 | ) | 998 | (3,378 | ) | ||||||||||
Income before taxes on income
|
21,768 | 6,363 | 54,873 | 13,006 | ||||||||||||
Taxes on income (tax benefit)
|
969 | 398 | (4,463 | ) | 1,146 | |||||||||||
Net income
|
$ | 20,799 | $ | 5,965 | $ | 59,336 | $ | 11,860 |
March 31,
|
June 30,
|
|||||||
2016
|
2015
|
|||||||
Unaudited
|
||||||||
ASSETS
|
||||||||
CURRENT ASSETS:
|
||||||||
Cash and cash equivalents
|
$ | 84,070 | $ | 144,750 | ||||
Restricted cash
|
944 | 3,639 | ||||||
Marketable Securities
|
44,059 | - | ||||||
Trade receivables, net
|
56,145 | 35,428 | ||||||
Prepaid expenses and other accounts receivable
|
18,613 | 32,645 | ||||||
Inventories
|
85,514 | 73,950 | ||||||
Total current assets
|
289,345 | 290,412 | ||||||
PROPERTY AND EQUIPMENT, NET
|
26,213 | 14,717 | ||||||
LONG-TERM ASSETS:
|
||||||||
Long-term marketable securities
|
43,151 | - | ||||||
Long-term prepaid expenses and lease deposits
|
440 | 529 | ||||||
Deferred tax assets, net
|
6,486 | - | ||||||
Intangible assets, net
|
737 | - | ||||||
50,814 | 529 | |||||||
Total assets
|
$ | 366,372 | $ | 305,658 | ||||
LIABILITIES AND STOCKHOLDERS' EQUITY
|
||||||||
CURRENT LIABILITIES:
|
||||||||
Trade payables
|
$ | 45,138 | $ | 80,684 | ||||
Employees and payroll accruals
|
12,358 | 6,814 | ||||||
Warranty obligations
|
13,510 | 9,431 | ||||||
Deferred revenues
|
2,642 | 1,676 | ||||||
Accrued expenses and other accounts payable
|
7,797 | 6,987 | ||||||
Total current liabilities
|
81,445 | 105,592 | ||||||
LONG-TERM LIABILITIES
|
||||||||
Warranty obligations
|
33,149 | 22,448 | ||||||
Deferred revenues
|
13,266 | 8,289 | ||||||
Lease incentive obligation
|
2,265 | 2,385 | ||||||
Total long-term liabilities
|
48,680 | 33,122 | ||||||
COMMITMENTS AND CONTINGENT LIABILITIES
|
||||||||
STOCKHOLDERS’ EQUITY:
|
||||||||
Share capital
|
4 | 4 | ||||||
Additional paid-in capital
|
296,480 | 287,152 | ||||||
Accumulated other comprehensive income (loss)
|
417 | (222 | ) | |||||
Accumulated deficit
|
(60,654 | ) | (119,990 | ) | ||||
Total stockholders’ equity
|
236,247 | 166,944 | ||||||
Total liabilities and stockholders’ equity
|
$ | 366,372 | $ | 305,658 |
Nine months ended
March 31,
|
||||||||
2016
|
2015
|
|||||||
Unaudited
|
||||||||
Cash flows provided by (used in) operating activities:
|
||||||||
Net income
|
$ | 59,336 | $ | 11,860 | ||||
Adjustments to reconcile net income to net cash provided by operating activities:
|
||||||||
Depreciation
|
2,601 | 1,647 | ||||||
Amortization of intangible assets
|
63 | - | ||||||
Amortization of premiums on available-for-sale marketable securities
|
209 | - | ||||||
Stock-based compensation related to employees and non-employees consultants stock options
|
6,689 | 1,750 | ||||||
Financial income, net related to term loan
|
- | (992 | ) | |||||
Remeasurement of warrants to purchase preferred and common stock
|
- | 2,065 | ||||||
Changes in assets and liabilities:
|
||||||||
Inventories
|
(11,446 | ) | (39,071 | ) | ||||
Prepaid expenses and other accounts receivable
|
13,186 | (12,198 | ) | |||||
Trade receivables, net
|
(20,681 | ) | (25,993 | ) | ||||
Deferred tax assets, net
|
(6,627 | ) | - | |||||
Trade payables
|
(35,554 | ) | 39,604 | |||||
Employees and payroll accruals
|
5,517 | 883 | ||||||
Warranty obligations
|
14,780 | 9,718 | ||||||
Deferred revenues
|
5,942 | 2,116 | ||||||
Accrued expenses and other accounts payable
|
497 | 2,733 | ||||||
Lease incentive obligation
|
(120 | ) | 2,243 | |||||
Net cash provided by (used in) operating activities
|
34,392 | (3,635 | ) | |||||
Cash flows used in investing activities:
|
||||||||
Purchase of property and equipment
|
(11,545 | ) | (8,254 | ) | ||||
Purchase of intangible assets
|
(800 | ) | - | |||||
Decrease (increase) in restricted cash
|
2,695 | (1,973 | ) | |||||
Decrease (increase) in short and long-term lease deposits
|
23 | (24 | ) | |||||
Purchases of available-for-sale marketable securities
|
(88,883 | ) | - | |||||
Maturities of available-for-sale marketable securities
|
1,000 | - | ||||||
Net cash used in investing activities
|
(97,510 | ) | (10,251 | ) | ||||
Cash flows from financing activities:
|
||||||||
Proceeds from short-term bank loans
|
- | 23,000 | ||||||
Repayments of short term loan
|
- | (36,326 | ) | |||||
Repayments of term loan
|
- | (5,919 | ) | |||||
Proceeds from issuance of stock
|
- | 24,712 | ||||||
Proceeds from IPO, net
|
- | 133,944 | ||||||
Proceeds from exercise of employees and non-employees consultants stock options
|
2,639 | 46 | ||||||
Net cash provided by financing activities
|
2,639 | 139,457 | ||||||
Increase (decrease) in cash and cash equivalents
|
(60,479 | ) | 125,571 | |||||
Cash and cash equivalents at the beginning of the period
|
144,750 | 9,754 | ||||||
Erosion due to exchange rate differences
|
(201 | ) | (121 | ) | ||||
Cash and cash equivalents at the end of the period
|
$ | 84,070 | $ | 135,204 |
Reconciliation of Non-GAAP Financial Measures
|
Reconciliation of GAAP to Non-GAAP Gross Profit
|
||||||||||||||||||||
Three months ended
|
Nine months ended
|
|||||||||||||||||||
Mar 31, 2016
|
Dec 31, 2015
|
Mar 31, 2015 (1)
|
Mar 31, 2016
|
Mar 31, 2015 (1)
|
||||||||||||||||
Gross profit (GAAP)
|
40,734 | 38,582 | 23,701 | 112,843 | 53,512 | |||||||||||||||
Stock-based compensation
|
246 | 209 | 142 | 635 | 254 | |||||||||||||||
Gross profit (Non-GAAP)
|
40,980 | 38,791 | 23,843 | 113,478 | 53,766 | |||||||||||||||
Reconciliation of GAAP to Non-GAAP Gross Margin
|
||||||||||||||||||||
Three months ended
|
Nine months ended
|
|||||||||||||||||||
Mar 31, 2016
|
Dec 31, 2015
|
Mar 31, 2015 (1)
|
Mar 31, 2016
|
Mar 31, 2015 (1)
|
||||||||||||||||
Gross margin (GAAP)
|
32.5 | % | 30.9 | % | 27.4 | % | 30.9 | % | 23.6 | % | ||||||||||
Stock-based compensation
|
0.2 | % | 0.2 | % | 0.2 | % | 0.2 | % | 0.1 | % | ||||||||||
Gross margin (Non-GAAP)
|
32.7 | % | 31.1 | % | 27.6 | % | 31.1 | % | 23.7 | % | ||||||||||
Reconciliation of GAAP to Non-GAAP Operating expenses
|
||||||||||||||||||||
Three months ended
|
Nine months ended
|
|||||||||||||||||||
Mar 31, 2016
|
Dec 31, 2015
|
Mar 31, 2015 (1)
|
Mar 31, 2016
|
Mar 31, 2015 (1)
|
||||||||||||||||
Operating expenses (GAAP)
|
20,995 | 19,320 | 13,902 | 58,968 | 37,128 | |||||||||||||||
Stock-based compensation R&D
|
724 | 518 | 184 | 1,637 | 450 | |||||||||||||||
Stock-based compensation S&M
|
842 | 749 | 292 | 2,207 | 546 | |||||||||||||||
Stock-based compensation G&A
|
819 | 750 | 354 | 2,210 | 502 | |||||||||||||||
Operating expenses (Non-GAAP)
|
18,610 | 17,303 | 13,072 | 52,914 | 35,630 | |||||||||||||||
Reconciliation of GAAP to Non-GAAP Operating income
|
||||||||||||||||||||
Three months ended
|
Nine months ended
|
|||||||||||||||||||
Mar 31, 2016
|
Dec 31, 2015
|
Mar 31, 2015 (1)
|
Mar 31, 2016
|
Mar 31, 2015 (1)
|
||||||||||||||||
Operating income (GAAP)
|
19,739 | 19,262 | 9,799 | 53,875 | 16,384 | |||||||||||||||
Stock-based compensation
|
2,631 | 2,226 | 972 | 6,689 | 1,752 | |||||||||||||||
Operating income (Non-GAAP)
|
22,370 | 21,488 | 10,771 | 60,564 | 18,136 | |||||||||||||||
Reconciliation of GAAP to Non-GAAP Finance expenses
|
||||||||||||||||||||
Three months ended
|
Nine months ended
|
|||||||||||||||||||
Mar 31, 2016
|
Dec 31, 2015
|
Mar 31, 2015 (1)
|
Mar 31, 2016
|
Mar 31, 2015 (1)
|
||||||||||||||||
Finance expenses (Income) (GAAP)
|
(2,029 | ) | 959 | 3,436 | (998 | ) | 3,378 | |||||||||||||
Warrants remeasurement
|
---- | ---- | 1,800 | ---- | 2,065 | |||||||||||||||
Finance expenses (Non-GAAP)
|
(2,029 | ) | 959 | 1,636 | (998 | ) | 1,313 | |||||||||||||
Reconciliation of GAAP to Non-GAAP Tax on income (Tax benefit)
|
||||||||||||||||||||
Three months ended
|
Nine months ended
|
|||||||||||||||||||
Mar 31, 2016
|
Dec 31, 2015
|
Mar 31, 2015 (1)
|
Mar 31, 2016
|
Mar 31, 2015 (1)
|
||||||||||||||||
Tax on income (Tax benefit) (GAAP)
|
969 | (5,802 | ) | 398 | (4,463 | ) | 1,146 | |||||||||||||
Tax benefit due to deferred tax asset
|
100 | 6,527 | ---- | 6,627 | ---- | |||||||||||||||
Tax on income (Tax benefit) (Non-GAAP)
|
1,069 | 725 | 398 | 2,164 | 1,146 | |||||||||||||||
Reconciliation of GAAP to Non-GAAP Net income
|
||||||||||||||||||||
Three months ended
|
Nine months ended
|
|||||||||||||||||||
Mar 31, 2016
|
Dec 31, 2015
|
Mar 31, 2015 (1)
|
Mar 31, 2016
|
Mar 31, 2015 (1)
|
||||||||||||||||
Net income (GAAP)
|
20,799 | 24,105 | 5,965 | 59,336 | 11,860 | |||||||||||||||
Stock-based compensation
|
2,631 | 2,226 | 972 | 6,689 | 1,752 | |||||||||||||||
Warrants remeasurement
|
---- | ---- | 1,800 | ---- | 2,065 | |||||||||||||||
Tax benefit due to deferred tax asset
|
(100 | ) | (6,527 | ) | ---- | (6,627 | ) | ---- | ||||||||||||
Net income (Non-GAAP)
|
23,330 | 19,804 | 8,737 | 59,398 | 15,677 |
Reconciliation of GAAP to Non-GAAP Net basic EPS
|
||||||||||||||||||||
Three months ended
|
Nine months ended
|
|||||||||||||||||||
Mar 31, 2016
|
Dec 31, 2015
|
Mar 31, 2015 (1)
|
Mar 31, 2016
|
Mar 31, 2015 (1)
|
||||||||||||||||
Net basic earnings per share (GAAP)
|
0.52 | 0.61 | 0.01 | 1.49 | 0.02 | |||||||||||||||
Stock-based compensation
|
0.06 | 0.06 | 0.03 | 0.17 | 0.05 | |||||||||||||||
Warrants remeasurement
|
---- | ---- | 0.04 | ---- | 0.07 | |||||||||||||||
Additional shares giving effect to IPO and conversion of preferred stock at the beginning of the periods
|
---- | ---- | 0.14 | ---- | 0.34 | |||||||||||||||
Tax benefit due to deferred tax asset
|
---- | (0.17 | ) | ---- | (0.16 | ) | ---- | |||||||||||||
Net basic earnings per share (Non-GAAP)
|
0.58 | 0.50 | 0.22 | 1.50 | 0.48 | |||||||||||||||
Reconciliation of GAAP to Non-GAAP No. of shares used in net basic EPS
|
||||||||||||||||||||
Three months ended
|
Nine months ended
|
|||||||||||||||||||
Mar 31, 2016
|
Dec 31, 2015
|
Mar 31, 2015 (1)
|
Mar 31, 2016
|
Mar 31, 2015 (1)
|
||||||||||||||||
Number of shares used in computing net basic earnings per share (GAAP)
|
40,362,093 | 39,511,967 | 2,822,893 | 39,725,227 | 2,817,090 | |||||||||||||||
Additional shares giving effect to IPO and conversion of preferred stock at the beginning of the periods
|
---- | ---- | 36,297,931 | ---- | 30,025,279 | |||||||||||||||
Number of shares used in computing net basic earnings per share (Non-GAAP)
|
40,362,093 | 39,511,967 | 39,120,824 | 39,725,227 | 32,842,369 | |||||||||||||||
Reconciliation of GAAP to Non-GAAP Net diluted EPS
|
||||||||||||||||||||
Three months ended
|
Nine months ended
|
|||||||||||||||||||
Mar 31, 2016
|
Dec 31, 2015
|
Mar 31, 2015 (1)
|
Mar 31, 2016
|
Mar 31, 2015 (1)
|
||||||||||||||||
Net diluted earnings per share (GAAP)
|
0.47 | 0.55 | 0.01 | 1.34 | 0.01 | |||||||||||||||
Stock-based compensation
|
0.04 | 0.03 | 0.01 | 0.11 | 0.05 | |||||||||||||||
Warrants remeasurement
|
---- | ---- | 0.04 | ---- | 0.05 | |||||||||||||||
Additional shares giving effect to IPO and conversion of preferred stock at the beginning of the periods
|
---- | ---- | 0.14 | ---- | 0.32 | |||||||||||||||
Tax benefit due to deferred tax asset
|
---- | (0.14 | ) | ---- | (0.14 | ) | ---- | |||||||||||||
Net diluted earnings per share (Non-GAAP)
|
0.51 | 0.44 | 0.20 | 1.31 | 0.43 | |||||||||||||||
Reconciliation of GAAP to Non-GAAP No. of shares used in Net diluted EPS
|
||||||||||||||||||||
Three months ended
|
Nine months ended
|
|||||||||||||||||||
Mar 31, 2016
|
Dec 31, 2015
|
Mar 31, 2015 (1)
|
Mar 31, 2016
|
Mar 31, 2015 (1)
|
||||||||||||||||
Number of shares used in computing net diluted earnings per share (GAAP)
|
44,577,901 | 44,007,348 | 7,099,046 | 44,347,071 | 5,534,903 | |||||||||||||||
Stock-based compensation
|
1,071,876 | 1,341,335 | 647,474 | 1,033,227 | 670,669 | |||||||||||||||
Warrants remeasurement
|
---- | 0 | 103,777 | 0 | 36,839 | |||||||||||||||
Additional shares giving effect to IPO and conversion of preferred stock at the beginning of the periods
|
---- | ---- | 36,297,931 | ---- | 30,025,279 | |||||||||||||||
Number of shares used in computing net diluted earnings per share (Non-GAAP)
|
45,649,777 | 45,348,683 | 44,148,228 | 45,380,298 | 36,267,690 |
(1) Assumes shares of common stock outstanding after accounting for the automatic conversion of the shares of preferred stock then outstanding into common stock at the beginning of fiscal year 2015.
|